Regional therapy of high grade astrocytomas

Seminars in Interventional Radiology

Volumn 15, Issue 4, 1998, Pages 365-371

  Manzione, James V ^a   Madajewicz, Stefan ^a   Roque, Clemente ^a   Roche, Patricia ^a   Tfayli, Arafat ^a   Shindo, Maisie L ^a  

^a STONY BROOK UNIVERSITY   (United States)

Author keywords

Astrocytomas; Chemotherapy; Regional therapy

Indexed keywords

ANTINEOPLASTIC AGENT; CARMUSTINE; ETOPOSIDE; LOMUSTINE; PROCARBAZINE; VINCRISTINE;

ADJUVANT CHEMOTHERAPY; ASTROCYTOMA; BRAIN CANCER; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER RADIOTHERAPY; CANCER SURGERY; DRUG DELIVERY SYSTEM; HUMAN; IMAGE ANALYSIS; INTRAARTERIAL DRUG ADMINISTRATION; REVIEW;

EID: 0032417181     PISSN: 07399529     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1057029     Document Type: Review

References (39)

1. Grossman SA, Norris LK. Adjuvant and neoadjuvant treatment for primary brain tumors in adults. Semin Oncol 1995;22:530-539
2. Grieg NH, Ries LG, Yancik R, et al. Increasing annual incidence of primary malignant brain tumors in the elderly. J Natl Cancer Inst 1990;82:1621-1624
3. Mao V, Desmeuler M, Semenciw RM, et al. Increasing brain cancer rates in Canada. Can Med Assoc J 1991;145: 1583-1591
4. Pedersen P-H, Marienhagen K, Mork S, et al. Migratory pattern of fetal rat brain cells and human glioma cells in the adult rat brain. Cancer Res 1993;53:5158-5165
5. Wie BA, Grossman SA, Wharam MD, et al. Dissemination of high grade astrocytomas (HGA) along white matter tracts (WMT): Observations and therapeutic implications. Proc ASCO 1993;12:177 (abstr)
6. Geer CP, Grossman SA. Extracellular fluid (ECF) flow along white matter tracts in brain: A potentially important mechanism for dissemination of primary brain tumors. Proc ASCO 1993;12:177 (abstr)
7. Lesser GJ, Grossman S. The chemotherapy of high-grade astrocytomas. Semin Oncol 1994;21:220-235
8. Walker MD, Alexander E, Hunt WE, et al. Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. J. Neurosurg 1978;49:333-343
9. Walker MD, Green SB, Byar DP, et al. Randomized comparisons of radiotherapy and nitrosoureas for the treatment of maligmant glioma after surgery. N Engl J Med 1980;303:1323-1329
10. Fine HA, Dear KBG, Loeffler JJ, et al. Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults. Cancer 1993;71:2585-2597
11. Chang CH, Horton J, Schoenfeld D, et al. Comparison of postoperative radiotherapy and combined postoperative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas. Cancer 1983;52: 997-1007
12. Gutin PH, Prados MD, Phillips TL, et al. External irradiation followed by an interstitial high activity iodine - 125 implant "boost" in the initial treatment of malignant gliomas: NCOG study 6G-82-2. Int J Radiat Oncol Biol Phys 1991;21:601-606
13. Loeffler JS, Alexander E, Shea WM, et al. Radiosurgery as part of the initial management of patients with malignant gliomas. J Clin Oncol 1992;10:1379-1385
14. Leibel SA, Scott CB, Pajak TF. The management of malignant gliomas with radiation therapy: Therapeutic results and research strategies. Semin Radiat Oncol 1991;1:32-49
15. Conrad CA, Milosavljevic VP, Yung WKA. Advances in chemotherapy for brain tumors. Neurologic Clinics 1995;13:795-812
16. Curran WJ, Scott CV, Horton J, et al. Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials. J Natl Cancer Inst 1993;85:701-710
17. Levin VA, Silver P, Hannigan J, et al. Superiority of post-radiotherapy adjuvant chemotherapy with CCNU, procarbasive and vincristine (PVC) over BCNU for anaplastic gliomas: NCOG 6G61 final report. Int J Radiat Oncol Biol Phys 1990;18:321-324
18. Grossman SA, Wharam M, Sheidler V, et al. Phase II study of continuous infusion of carmustine and cisplatin followed by cranial irradiation in adults with newly diagnosed high-grade astrocytoma. J Clin Oncol 1997;15: 2596-2603
19. Gilbert MR, Lunsford LD, Kondziolka D, et al. A phase II trial of continuous infusion chemotherapy, external beam radiotherapy and local boost radiotherapy for malignant gliomas. Proc Am Soc Clin Oncol 1993;12:176 (abstr)
20. Fenstermacher JD, Cowles AL. Theoretic limitations of intracarotid infusions in brain tumor chemotherapy. Cancer Treat Rep 1977;61:519-526
21. Sipos EP, Brem H. New delivery systems for brain tumor therapy. Neurologic Clinics 1995;13:813-825
22. Greenberg HS, Ensminger WD, Chandler WF. Intra-arterial BCNU chemotherapy for treatment of malignant gliomas of the central nervous system. J Neurosurg 1984; 61:523-429
23. Shapiro WR, Green SB, Burger PC, et al. A randomized comparison of intra-arterial versus intravenous BCNU, with or without intravenous 5-flourouracil, for newly diagnosed patients with malignant glioma. J Neurosurg 1992;76:772-781
24. Madajewicz S, Chowhan N, Iliya A, et al. Intracarotid chemotherapy with etoposide and cisplatin for malignant brain tumors. Cancer 1991;67:2844-2849
25. Madajewicz S, Chowhan N, Roque C, et al. Intraarterial infusion of VP-16 and cisplatin in treatment of high grade gliomas. Cancer (accepted for publication)
26. Black KL, Cloughesy T, Huang S-C, et al. Intracarotid infusion of RMP-7, a bradykinin analog, and transport of galliukm-68 ethylenediamine tetraacetic acid into human gliomas. J Neurosurg 1997;86:603-609
27. Chiras J, Dormont D, Fauchon F, et al. Intra-arterial chemotherapy of malignant glimas. J Neuroradiol 1988; 15:31-48
28. Savarej N, Lu K, Raulston GL, et al. Comparison of CNS penetration, tissue distribution, and pharmacology of 4-demethylepipodophyllotoxin 9 - (4,6-0- ethylidene - beta - D-glucopyranoside) (VP-16, NSC - 141540) intracarotid (IC) vs intravenous administration (IV) in dogs. Proc Am Assoc Cancer Res 1982;23:201 (abstr)
29. Spigelman MK, Zappulla RA, Stauchen JA, et al. Etoposide induced blood-brain barrier disruption in rats: duration of opening and histological sequelae. Cancer Res 1986;46:1453-1457
30. Stewart DJ, Wallace S, Feun L. A phase I study of intracarotid artery infusion of CIA-diamminedichloroplatinum in patients with recurrent malignant intracerebral tumors. Cancer Res 1982;42:2059-2062
31. Dropcho EJ, Rosenfeld SS, Morawetz RB, et al. Preradiation intracarotid cisplatin treatment of newly diagnosed anaplastic gliomas. J Clin Oncol 1992;10:452-458
32. Feun LG, Wallace S, Stewart DJ, et al. Intracarotid infusion of cis-diamminedichloroplatinum in the treatment of recurrent malignant brain tumors. Cancer 1984;54:794-799
33. Lehane DE, Ehni G, Horowitz B, et al. Adjurant therapy for patients with high grade malignant gliomas using intraarterial cis-platinum, CCNU and radiation therapy. In Jones SE, Salmon S (Eds.) Adjuvant Therapy of Cancer, vol IV, Grune and Stratton, 1984
34. Tfayli A, Hentschel P, Madajewicz S, et al. Toxicities related to intraarterial infusion of cisplatin and etoposide in patients with brain tumors. J Neuroncol (submitted)
35. Matsukado K, Inamura T, Nakano S, et al. Enhanced tumor uptake of carboplatin and survival in glioma-bearing rats by intracarotid infusion of bradykinin analog, RMP-7. Neurosurgery 1996;39:125-134
36. Brem H, Piantadosi S, Burger PC, et al. Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas. Lancet 1995;345:1008-1012
37. Brem H, Mahaley MSJ, Vick NA, et al. Interstitial chemotherapy with drug polymer implants for the treatment of recurrent gliomas. J Neurosurg 1991;74:441-446
38. Grossman SA, Reinhard C, Colvin OM, et al. The intracerebral distribution of BCNU delivered by surgically implanted biodegradable polymers. J Neurosurg 1992;76: 640-647
39. Tamargo RJ, Myseros JS, Epstein JI, et al. Interstitial chemotherapy of the 9L gliosarcoma: Controlled release polymers for drug delivery in the brain. Cancer Res 1993;53:329-333